Amanta Healthcare Limited (NSE:AMANTA)
201.86
+3.95 (2.00%)
Last updated: Sep 8, 2026, 3:14 PM IST
Amanta Healthcare Revenue
Amanta Healthcare had revenue of 688.03M INR in the quarter ending June 30, 2026, with 5.35% growth. This brings the company's revenue in the last twelve months to 2.91B, up 7.08% year-over-year. In the fiscal year ending March 31, 2026, Amanta Healthcare had annual revenue of 2.88B with 4.78% growth.
Revenue (ttm)
2.91B
Revenue Growth
+7.08%
P/S Ratio
2.69
Revenue / Employee
6.33M
Employees
460
Market Cap
7.84B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.88B | 131.35M | 4.78% |
| Mar 31, 2025 | 2.75B | -56.32M | -2.01% |
| Mar 31, 2024 | 2.80B | 212.11M | 8.19% |
| Mar 31, 2023 | 2.59B | 336.88M | 14.94% |
| Mar 31, 2022 | 2.25B | 541.47M | 31.61% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.73B |
| Windlas Biotech | 9.42B |
| Sigachi Industries | 4.76B |
| Beta Drugs | 4.10B |
| Valiant Laboratories | 3.06B |
| Jagsonpal Pharmaceuticals | 2.94B |
| Sakar Healthcare | 2.72B |
| Anlon Healthcare | 2.26B |